Mouse Testicular Mkrn3 Expression Is Primarily Interstitial, Increases Peripubertally, and Is Responsive to LH/hCG
Endocrinology · 2023
DOI: 10.1210/endocr/bqad123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology, 2023. Verfasst von Sidney A Pereira und 9 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Pharmacology Laboratory, School of Health Sciences, University of Brasilia, Brasilia-DF, Brazil. Hauptthemen laut MEDLINE: Chorionic Gonadotropin, Luteinizing Hormone, Puberty, Precocious, Ubiquitin-Protein Ligases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NICHD NIH HHS, NIH.
Abstract (Originalsprache)
Studies in humans and mice support a role for Makorin RING finger protein 3 (MKRN3) as an inhibitor of gonadotropin-releasing hormone (GnRH) secretion prepubertally, and its loss of function is the most common genetic cause of central precocious puberty in humans. Studies have shown that the gonads can synthesize neuropeptides and express MKRN3/Mkrn3 mRNA. Therefore, we aimed to investigate the spatiotemporal expression pattern of Mkrn3 in gonads during sexual development, and its potential regulation in the functional testicular compartments by gonadotropins. Mkrn3 mRNA was detected in testes and ovaries of wild-type mice at all ages evaluated, with a sexually dimorphic expression pattern between male and female gonads. Mkrn3 expression was highest peripubertally in the testes, whereas it was lower peripubertally than prepubertally in the ovaries. Mkrn3 is expressed primarily in the interstitial compartment of the testes but was also detected at low levels in the seminiferous tubules. In vitro studies demonstrated that Mkrn3 mRNA levels increased in human chorionic gonadotropin (hCG)–treated Leydig cell primary cultures. Acute administration of a GnRH agonist in adult mice increased Mkrn3 expression in testes, whereas inhibition of the hypothalamic–pituitary–gonadal axis by chronic administration of GnRH agonist had the opposite effect. Finally, we found that hCG increased Mkrn3 mRNA levels in a dose-dependent manner. Taken together, our developmental expression analyses, in vitro and in vivo studies show that Mkrn3 is expressed in the testes, predominantly in the interstitial compartment, and that Mkrn3 expression increases after puberty and is responsive to luteinizing hormone/hCG stimulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Pharmacology Laboratory, School of Health Sciences, University of Brasilia, Brasilia-DF, Brazil.
- Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
ORCID-Profile: Sidney A Pereira, Lydie Naulé
Förderung
- NIH HHS
- NICHD NIH HHS
- NIH
Zitieren
APA
Pereira, S. A., Oliveira, F. C. B., Naulé, L., Royer, C., Neves, F. A. R., Abreu, A. P., Carroll, R. S., Kaiser, U. B., Coelho, M. S., & Lofrano-Porto, A. (2023). Mouse Testicular Mkrn3 Expression Is Primarily Interstitial, Increases Peripubertally, and Is Responsive to LH/hCG. Endocrinology. https://doi.org/10.1210/endocr/bqad123
Vancouver
Pereira SA, Oliveira FCB, Naulé L, Royer C, Neves FAR, Abreu AP, et al. Mouse Testicular Mkrn3 Expression Is Primarily Interstitial, Increases Peripubertally, and Is Responsive to LH/hCG. Endocrinology. 2023. doi:10.1210/endocr/bqad123
BibTeX
@article{Pereira2023,
author = {Pereira, Sidney A and Oliveira, Fernanda C B and Naulé, Lydie and Royer, Carine and Neves, Francisco A R and Abreu, Ana Paula and Carroll, Rona S and Kaiser, Ursula B and Coelho, Michella S and Lofrano-Porto, Adriana},
title = {Mouse Testicular Mkrn3 Expression Is Primarily Interstitial, Increases Peripubertally, and Is Responsive to LH/hCG},
journal = {Endocrinology},
year = {2023},
doi = {10.1210/endocr/bqad123}
}
EUVIMED